Functional Pancreatic Neuroendocrine Neoplasms: An Overview
Open Access
- 1 August 2025
- journal article
- review article
- Published by MDPI AG in Endocrines
- Vol. 6 (3) , 38
Abstract
Pancreatic neuroendocrine neoplasms (PNENs) are a diverse group of rare tumor subtypes, representing less than 2% of all pancreatic tumors. Often detected late in the clinical course, they are associated with high rates of morbidity and mortality. Hereditary syndromes such as multiple endocrine neoplasia type-1 and von Hippel–Lindau are associated with the development of PNENs, although only a small portion of total tumors have a genetic basis. This review aims to explore the recent advances in laboratory diagnostics, imaging modalities, medical management, and surgical approaches to hormone-producing PNENs (including some common, less common, and some rare subtypes), with the goal of assisting physicians in the integration of evidence-based information into their practice.Keywords
This publication has 161 references indexed in Scilit:
- Diagnostic and prognostic biomarkers for pancreatic neuroendocrine neoplasmsDie Pathologie, 2024
- Treatment options of metastatic and nonmetastatic VIPoma: a reviewLangenbeck's Archives of Surgery, 2022
- Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine TumorsJAMA Network Open, 2022
- Gastric Peptides—Gastrin and SomatostatinComprehensive Physiology, 2020
- Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysisCancer Medicine, 2018
- Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycleEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversiesCancer, 2008
- Medical treatment of gastrinomasWiener klinische Wochenschrift, 2007
- Glucagonomas/diabetico-dermatogenic syndrome (DDS): A statistical evaluation of 407 reported casesJournal of Hepato-Biliary-Pancreatic Surgery, 1998